Angiotensin-converting enzyme gene D-allele and the severity of coronary artery disease

Maria-Cristina Vladeanu1, Iris Bararu Bojan1, Andrei Bojan2

  • 1Department of Physiopathology, 'Grigore T. Popa' University of Medicine and Pharmacy, 700115 Iasi, Romania.

Insights

The angiotensin-converting enzyme (ACE) D-allele is linked to increased risk of severe coronary artery disease (CAD) and acute cardiac events. This genetic factor, particularly the DD genotype, interacts with other risk factors to worsen outcomes.

Area of Science:

  • Cardiovascular Genetics
  • Molecular Cardiology
  • Genetic Epidemiology

Background:

  • Coronary artery disease (CAD) is a leading global cause of death.
  • Early diagnosis of CAD is crucial for preventing acute cardiovascular events.
  • The angiotensin-converting enzyme (ACE) plays a key role in cardiovascular regulation.

Purpose of the Study:

  • To investigate the association between ACE gene polymorphism (I/D) and the severity of CAD.
  • To determine if specific ACE genotypes (II, ID, DD) correlate with acute coronary syndromes.
  • To explore the interaction between ACE genotypes, CAD severity, and traditional risk factors.

Main Methods:

  • Study included 154 patients admitted with acute coronary syndromes.
  • Coronary angiography was performed to assess the degree of coronary stenosis.
  • ACE genotypes were determined for all participating patients.

Main Results:

  • The D-allele of the ACE gene was found to be associated with a higher risk of acute coronary events.
  • A significant correlation was observed between the D-allele and severe coronary stenosis.
  • The study highlighted an interaction between the risk genotype (D-allele) and risk phenotype (classic risk factors).

Conclusions:

  • The D-allele of the ACE gene is a significant risk factor for acute coronary events and severe CAD.
  • Genetic predisposition, as indicated by ACE polymorphism, can exacerbate cardiovascular risk.
  • Understanding ACE genotype may aid in risk stratification for patients with coronary artery disease.

Related Concept Videos

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.1K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
721
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
737
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.2K
Multiple Allele Traits01:49

Multiple Allele Traits

The Concept of Multiple Allelism
37.5K
Genetic Lingo01:11

Genetic Lingo

Overview
112.8K